News and events

Sterile injectable manufacturing at Wockhardt UK set to double output in 2014

An expansion to our sterile injectable manufacturing facility in Wrexham is planned during the third quarter of 2014. A high-speed combination line for vials and ampoules will be installed, which aims to double the output of the facility, which is already looking set to produce approximately 14 million units in 2013.  

Product catalogue

Excludes Private Label

View all products >

Our Products

Our product range

Wockhardt UK specialises in the manufacture and supply of generic and also branded medicines, with a constantly growing portfolio of over 350 products.

Our products cover most therapy areas including anticoagulation, pain management, dermatitis, anti-infectives, diabetes and antibiotics and are available in a wide range of preparations, ranging from tablets, capsules and injections, through to liquid medicines, sachets, ointments and creams.

Read more >